276 related articles for article (PubMed ID: 19846958)
21. Novel radioimmunopharmaceuticals for cancer imaging and therapy.
Sharkey RM; Goldenberg DM
Curr Opin Investig Drugs; 2008 Dec; 9(12):1302-16. PubMed ID: 19037837
[TBL] [Abstract][Full Text] [Related]
22. New approaches for imaging and therapy of solid cancer.
Sollini M; Boni R; Traino AC; Lazzeri E; Pasqualetti F; Modeo L; Mariani G; Petrini M; Erba PA
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):168-83. PubMed ID: 25693421
[TBL] [Abstract][Full Text] [Related]
23. The bright future of radionuclides for cancer therapy.
Nijsen JF; Krijger GC; van Het Schip AD
Anticancer Agents Med Chem; 2007 May; 7(3):271-90. PubMed ID: 17504155
[TBL] [Abstract][Full Text] [Related]
24. Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.
Carter LM; Poty S; Sharma SK; Lewis JS
J Labelled Comp Radiopharm; 2018 Jul; 61(9):611-635. PubMed ID: 29412489
[TBL] [Abstract][Full Text] [Related]
25. Biomedical nanotechnology for cancer.
Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
[TBL] [Abstract][Full Text] [Related]
26. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
Muthu MS; Leong DT; Mei L; Feng SS
Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
[TBL] [Abstract][Full Text] [Related]
27. Quantum dots-bevacizumab complexes for in vivo imaging of tumors.
Gazouli M; Bouziotis P; Lyberopoulou A; Ikonomopoulos J; Papalois A; Anagnou NP; Efstathopoulos EP
In Vivo; 2014; 28(6):1091-5. PubMed ID: 25398804
[TBL] [Abstract][Full Text] [Related]
28. Altering pharmacokinetics of radiolabeled antibodies by the interposition of metabolizable linkages. Metabolizable linkers and pharmacokinetics of monoclonal antibodies.
Akizawa H; Arano Y
Q J Nucl Med; 2002 Sep; 46(3):206-23. PubMed ID: 12134137
[TBL] [Abstract][Full Text] [Related]
29. The role of radioisotopes in radiation oncology.
Park CH
Semin Oncol; 1997 Dec; 24(6):639-54. PubMed ID: 9422261
[TBL] [Abstract][Full Text] [Related]
30. Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.
Chang CH; Stabin MG; Chang YJ; Chen LC; Chen MH; Chang TJ; Lee TW; Ting G
Cancer Biother Radiopharm; 2008 Dec; 23(6):749-58. PubMed ID: 19111045
[TBL] [Abstract][Full Text] [Related]
31. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
de Visser M; Verwijnen SM; de Jong M
Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
[TBL] [Abstract][Full Text] [Related]
32. From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications.
Figuerola A; Di Corato R; Manna L; Pellegrino T
Pharmacol Res; 2010 Aug; 62(2):126-43. PubMed ID: 20044004
[TBL] [Abstract][Full Text] [Related]
33. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging.
Rhyner MN; Smith AM; Gao X; Mao H; Yang L; Nie S
Nanomedicine (Lond); 2006 Aug; 1(2):209-17. PubMed ID: 17716110
[TBL] [Abstract][Full Text] [Related]
34. Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?
Pant K; Sedláček O; Nadar RA; Hrubý M; Stephan H
Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28218487
[TBL] [Abstract][Full Text] [Related]
35. Preclinical imaging and treatment of cancer: the use of animal models beyond rodents.
Axiak-Bechtel SM; Maitz CA; Selting KA; Bryan JN
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):303-16. PubMed ID: 26200223
[TBL] [Abstract][Full Text] [Related]
36. The emerging role of copper-64 radiopharmaceuticals as cancer theranostics.
Boschi A; Martini P; Janevik-Ivanovska E; Duatti A
Drug Discov Today; 2018 Aug; 23(8):1489-1501. PubMed ID: 29635027
[TBL] [Abstract][Full Text] [Related]
37. Nanotechnology applications in cancer.
Nie S; Xing Y; Kim GJ; Simons JW
Annu Rev Biomed Eng; 2007; 9():257-88. PubMed ID: 17439359
[TBL] [Abstract][Full Text] [Related]
38. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
Eberle AN; Mild G
J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
[TBL] [Abstract][Full Text] [Related]
39. Theranostic Aspects: Treatment of Cancer by Nanotechnology.
Sarkar B; Paira P
Mini Rev Med Chem; 2018; 18(11):969-975. PubMed ID: 29189149
[TBL] [Abstract][Full Text] [Related]
40. Radionuclide cancer therapy.
Hoefnagel CA
Ann Nucl Med; 1998 Apr; 12(2):61-70. PubMed ID: 9637275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
